Multiple research collaborations have been formed with MSKCC with focuses in kidney cancer, chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
MSKCC provided CGI with a multitude of lymphoma specimens of varying histologies with known clinical outcomes for the and clinical validations of MatBAÂ® for CLL, DLBCL, MCL and FL. CGI also received cores of FFPE tumor material spear-heading and providing justification for the use of this tissue type in array-CGH.
A biological material transfer agreement allowed the evaluation the first application of CGIâ€™s proprietary array-CGH product line, UroGenRAâ„¢, in the diagnosis and subtyping of renal mass aspirates/core biopsies. The specimens were also used to compare UroGenRAâ„¢ with routine pathology testing.